ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $151,000 | +67.8% | 25,000 | 0.0% | 0.03% | +62.5% |
| Q3 2019 | $90,000 | +34.3% | 25,000 | 0.0% | 0.02% | +33.3% |
| Q2 2019 | $67,000 | -9.5% | 25,000 | 0.0% | 0.01% | -7.7% |
| Q1 2019 | $74,000 | +85.0% | 25,000 | 0.0% | 0.01% | +62.5% |
| Q4 2018 | $40,000 | -56.5% | 25,000 | 0.0% | 0.01% | -50.0% |
| Q3 2018 | $92,000 | +8.2% | 25,000 | -16.7% | 0.02% | +6.7% |
| Q2 2018 | $85,000 | -23.4% | 30,000 | 0.0% | 0.02% | -25.0% |
| Q1 2018 | $111,000 | +29.1% | 30,000 | 0.0% | 0.02% | +33.3% |
| Q4 2017 | $86,000 | -36.3% | 30,000 | 0.0% | 0.02% | -37.5% |
| Q3 2017 | $135,000 | -26.6% | 30,000 | -25.0% | 0.02% | -31.4% |
| Q2 2017 | $184,000 | +9.5% | 40,000 | 0.0% | 0.04% | +9.4% |
| Q1 2017 | $168,000 | +1.8% | 40,000 | 0.0% | 0.03% | -3.0% |
| Q4 2016 | $165,000 | -49.1% | 40,000 | 0.0% | 0.03% | -50.7% |
| Q3 2016 | $324,000 | +3.8% | 40,000 | 0.0% | 0.07% | +1.5% |
| Q2 2016 | $312,000 | -4.9% | 40,000 | 0.0% | 0.07% | -5.7% |
| Q1 2016 | $328,000 | -24.1% | 40,000 | 0.0% | 0.07% | -21.3% |
| Q4 2015 | $432,000 | +56.5% | 40,000 | 0.0% | 0.09% | +48.3% |
| Q3 2015 | $276,000 | – | 40,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |